People: Clovis Oncology Inc (CLVS.OQ)
21 Jun 2019
Mr. Daniel W. (Dan) Muehl is Executive Vice President of Finance, Principal Accounting Officer and Principal Financial Officer of the Company. Mr. Muehl was appointed our Principal Accounting Officer and Principal Financial Officer in March 2016 and has served as our Executive Vice President of Finance since February 2019 and, prior to that, as our Senior Vice President of Finance from September 2016 and Vice President of Finance since 2015. Previously, Mr. Muehl was the Chief Financial Officer of biotechnology company Somalogic, Inc. from 2014 to 2015 and prior to that the Chief Financial Officer of bio-industrial company OPX Biotechnologies, Inc. from 2010 to 2014. He earned a Bachelor of Science degree in accounting from the University of Massachusetts—Amherst and received his Certified Public Accountant certificate in 1990.
|Total Annual Compensation, USD||580,169|
|Restricted Stock Award, USD||525,870|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||403,544|
|Fiscal Year Total, USD||1,509,580|